Login
Toggle navigation
Videos
Categories
Trending
Gianmarco Lanza, CEO of FAE Technology SB S.p.A., will be the guest speaker at the upcoming free Smart Webinar.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Videointervista Gianmarco Lanza – CEO FAE Technology
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Unlocking Mexico's Energy Potential: An Interview with Steve Hansen, CEO of International Frontier Resources
00:10:00
Nuclear Weapons: Cold War Deterrence and Modern Challenges|George Shultz
00:10:00
Low Lift, High Impact- Changing the Investing Narrative|Lolita Taub,General Partner,Ganas Ventures
00:10:00
Invests in innovative food and agriculture companies|Amanda Donohue-Hansen,Managing Director,Cultivian Sandbox Ventures
00:10:00
Forging a More Perfect Union: A Journey of Community and Service|Lt. Col. Alphanso Adams
00:10:00
Goh Peng Ooi on Game Theory and the Mathematical Solutions for Global Challenges | Goh Peng Ooi , Founder, Silverlake Axis Ltd.
00:10:00
Interview with Peter Ledwidge: Mako Gold's Exploration and Growth Strategies in West Africa
00:10:00
From Near Failure to $203M Success: Loom CEO Joe Thomas Shares Secrets of SaaS Scaling and Agility Amidst Uncertainty|Joe Thomas, CEO and Co-founder of Loom
00:10:00
John Cogan Discusses the Historical Forces Driving the Growth of Federal Entitlements|Michael Franc
00:10:00
Student Accommodation & Sustainability: Quickfire Q&A with Unite's CFO Joe Lister
00:10:00
Tinka Resources CEO Graham Carman Highlights Exciting Times Amid Zinc Surge and Exploration Milestones
00:00:00
Mike Lampron Chief Executive Officer,Mach7 Technologies Ltd